Somnigroup International Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, auditor ratification, executive compensation, and an amendment to double authorized shares. All proposals passed by majority vote, with no questions raised by stockholders.
-
Q1 2026 saw 12% sales growth and 20% adjusted EPS growth, with strong cash flow and market outperformance despite industry headwinds. 2026 guidance was reaffirmed, with EPS expected at $3.00–$3.40 and continued margin expansion, while the Leggett & Platt merger is set to close by year-end.
-
Somnigroup outlined its strategy for sustained growth, targeting 24% EPS CAGR through 2028, driven by vertical integration, omnichannel reach, and innovation. Updated guidance reflects strong synergy realization, operational excellence, and disciplined capital allocation, with further upside possible from logistics and marketing efficiencies.
Fiscal Year 2025
-
Record Q4 and full-year results were achieved despite industry headwinds, with strong sales, margin expansion, and accelerated synergy realization from the Mattress Firm combination. 2026 guidance anticipates continued growth, robust cash flow, and increased shareholder returns.
-
Record Q3 results with 63% sales growth and 16% EPS increase, driven by Mattress Firm integration and strong international performance. Raised 2025 EPS guidance, accelerated synergy realization, and announced increased shareholder returns for 2026.
-
Record Q2 net sales and EBITDA driven by Mattress Firm integration and international growth. Raised 2025 EPS guidance, with synergy realization ahead of plan and strong product launches offsetting industry headwinds.
-
Q1 2025 saw $1.6B in sales and $0.49 adjusted EPS, with strong international growth and resilience despite weak U.S. demand. Mattress Firm integration is ahead of plan, synergy targets increased, and tariff impacts are being mitigated. 2025 guidance was revised lower due to industry softness.
-
The acquisition of Mattress Firm has closed, forming the world's largest bedding company and prompting a rebrand to Somnigroup International. The deal accelerates vertical integration, enhances innovation, and is expected to be accretive from day one, with full synergy benefits realized over 3–4 years.
Fiscal Year 2024
-
Q4 2024 saw $1.2B in sales and $0.60 adjusted EPS, with strong international growth and record margins. The Mattress Firm merger positions the company for long-term growth, targeting 20% EPS CAGR through 2028 and $100M+ in synergies. Guidance anticipates stable industry conditions in 2025.
-
Net sales rose 2% to $1.3B and adjusted EBITDA grew 6% year-over-year, with strong international and brand performance. 2024 guidance implies 4% EPS growth, and the Mattress Firm acquisition is progressing amid industry volumes 30% below 2021 peak.
-
Q2 2024 saw $1.2B in sales, 6% adjusted EBITDA growth, and 9% higher EPS, with strong gross margin expansion and robust free cash flow. Guidance calls for flat full-year sales, 6% EPS growth, and continued outperformance versus a declining industry.
-
FTC litigation challenges the planned combination, but management remains confident in the transaction's legal and competitive merits. Commitments to divestitures and multi-brand retailing aim to address regulatory concerns, with litigation expected to conclude by early 2025.